0001739614-18-000002.txt : 20180511 0001739614-18-000002.hdr.sgml : 20180511 20180511113243 ACCESSION NUMBER: 0001739614-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180511 DATE AS OF CHANGE: 20180511 EFFECTIVENESS DATE: 20180511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibrx, Inc. CENTRAL INDEX KEY: 0001739614 IRS NUMBER: 824257312 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312173 FILM NUMBER: 18825720 BUSINESS ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD, SUITE 280 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 759-1499 MAIL ADDRESS: STREET 1: 11099 N. TORREY PINES ROAD, SUITE 280 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001739614 Inhibrx, Inc. 11099 N. TORREY PINES ROAD, SUITE 280 LA JOLLA CA CALIFORNIA 92037 (858) 759-1499 DELAWARE TENIUM THERAPEUTICS, INC. None Corporation true 2017 Mark Lappe c/o Inhibrx, Inc. 11099 N. Torrey Pines Road, Suite 280 La Jolla CA CALIFORNIA 92037 Executive Officer Director Brendan Eckelman c/o Inhibrx, Inc. 11099 N. Torrey Pines Road, Suite 280 La Jolla CA CALIFORNIA 92037 Director Jon Faiz Kayyem c/o Inhibrx, Inc. 11099 N. Torrey Pines Road, Suite 280 La Jolla CA CALIFORNIA 92037 Director Margery Fischbein c/o Inhibrx, Inc. 11099 N. Torrey Pines Road, Suite 280 La Jolla CA CALIFORNIA 92037 Director Doug Forsyth c/o Inhibrx, Inc. 11099 N. Torrey Pines Road, Suite 280 La Jolla CA CALIFORNIA 92037 Director Judith Li c/o Inhibrx, Inc. 11099 N. Torrey Pines Road, Suite 280 La Jolla CA CALIFORNIA 92037 Director Biotechnology Decline to Disclose 06b false 2018-05-04 false true false 0 75000000 3550000 71450000 false 6 0 0 0 false Inhibrx, Inc. /s/ Mark Lappe Mark Lappe Chief Executive Officer 2018-05-11